Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease
Yaerim Kim, Seungyeup Han
Korean J Intern Med. 2023;38(3):322-331.   Published online 2023 Apr 25     DOI: https://doi.org/10.3904/kjim.2022.376
Citations to this article as recorded by Crossref logo
Navigating advanced polycystic kidney disease: a case study of bilateral nephrectomy and life-saving transplant
Fathimath Suooda, Fathimath Maleesha, Fathmath Zuha Ali, Yulia Karpovich Ivanovna
International Journal of Research in Medical Sciences.2025; 13(3): 1264.     CrossRef
Evaluating physician confidence and barriers in prescribing tolvaptan for ADPKD management: a comprehensive online survey study
Niloufar Ebrahimi, Mehrbod Vakhshoori, Fouad Chebib, Pranav S. Garimella, Yasar Caliskan, Amir Abdipour, Sayna Norouzi
Journal of Nephrology.2024; 37(8): 2429.     CrossRef